Australia is closely watching the arrival of retatrutide, a innovative dual GIP and GLP-1 receptor medication , representing a potential advance in obesity treatment . Early study data have demonstrated https://giantlivbike312948.ouyawiki.com/2668061/emerging_medication_in_australia_a_promising_hope_for_weight_loss